Jump to content
RemedySpot.com

Thimerosal – Is it really irrelevant?

Rate this topic


Guest guest

Recommended Posts

Contact Dermatitis

Volume 53 Page 324 - December 2005

doi:10.1111/j.0105-1873.2005.00591.x

Volume 53 Issue 6

Thimerosal – Is it really irrelevant?

Dan Slodownik1 and Arieh Ingber1*

Recently, several investigators claimed that thimerosal is one of

the most irrelevant allergens existing in screening for contact

dermatitis. 508 patients who were suspected to have allergic contact

dermatitis were patch tested at our clinic. They completed a

questionnaire including medical, demographic and occupational

details. We used the standard tray of chemotechnique diagnostics

(Malmö, Sweden) and additional series, which were case relevant. The

relevance of the allergic reaction to thimerosal was scored from 1

to 6. 19 patients (3.7%) had an allergic reaction to thimerosal. 6

(31.5%) had a definite relevance and 8 (42.1%) had a probable

relevance. Only 3 patients (15.8%) had an irrelevant reaction. SPIN

value (significance–prevalence index number) was 2281. We found a

high proportion of mechanics (42.1%) among the patients who had

positive reaction to thimerosal (P < 0.0001). Although previous

reports found thimerosal highly irrelevant, our daily experience

being supported by the above data indicates that positive reactions

to thimerosal could be relevant for many patients.

http://www.blackwell-synergy.com/doi/abs/10.1111/j.0105-

1873.2005.00591.x

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...